BPM
VRTX icon

Bowling Portfolio Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bowling Portfolio Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.76M Buy
+6,068
New +$1.75M 0.48% 62
2018
Q4 		– Sell
-6,131
Closed -$1.18M – 402
2018
Q3 		$1.18M Sell
6,131
-11,174
-65% -$1.99M 0.17% 213
2018
Q2 		$2.94M Buy
+17,305
New +$2.68M 0.41% 73

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bowling Portfolio Management's VRTX Position: Q3 2022 in Review

Bowling Portfolio Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2022: 6,068 shares worth $1.76M. The stake represents 0.48% of the portfolio and ranks #62 among its holdings. This is a return to the name: Bowling Portfolio Management previously reported a position in VRTX as recently as Q3 2018.

Bowling Portfolio Management first reported a position in VRTX in Q2 2018 and has held it in 3 quarters since. The position peaked at $2.94M in Q2 2018. 1,125 funds tracked by Wall St. Rank hold VRTX as of Q3 2022.

  • Bowling Portfolio Management held 6,068 shares of Vertex Pharmaceuticals worth $1.76M as of Q3 2022.
  • Vertex Pharmaceuticals was a new Bowling Portfolio Management position in Q3 2022.
  • Vertex Pharmaceuticals made up 0.48% of Bowling Portfolio Management's portfolio in Q3 2022, its #62 holding.
  • Bowling Portfolio Management first reported a position in Vertex Pharmaceuticals in Q2 2018 and has held it in 3 quarters since.
  • Bowling Portfolio Management's Vertex Pharmaceuticals position peaked at $2.94M in Q2 2018.
  • 1,125 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2022.

Based on Bowling Portfolio Management's 13F filing for Q3 2022, filed 4 Oct 2022.